Suzhou Operating Income from 2010 to 2024

301258 Stock   28.43  0.49  1.75%   
Suzhou Fushilai's Operating Income is decreasing over the years with slightly volatile fluctuation. Overall, Operating Income is expected to go to about 119.7 M this year. Operating Income is earnings before interest and taxes (EBIT), representing the amount of profit Suzhou Fushilai Pharmaceutical generates from its operations. View All Fundamentals
 
Operating Income  
First Reported
2010-12-31
Previous Quarter
96.2 M
Current Value
119.7 M
Quarterly Volatility
21.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Suzhou Fushilai financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suzhou Fushilai's main balance sheet or income statement drivers, such as Tax Provision of 17.3 M, Net Interest Income of 4.6 M or Interest Income of 5.1 M, as well as many indicators such as . Suzhou financial statements analysis is a perfect complement when working with Suzhou Fushilai Valuation or Volatility modules.
  
This module can also supplement various Suzhou Fushilai Technical models . Check out the analysis of Suzhou Fushilai Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Suzhou Stock

Suzhou Fushilai financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Fushilai security.